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ABSTRACT
Background: The risk of ischaemic heart disease
(IHD) is largely influenced by lifestyle. Interestingly,
cohort studies show that anxiety in general is
associated with increased risk of IHD, independent of
established risk factors for cardiovascular disease.
Health anxiety is a specific type of anxiety
characterised by preoccupation of having, acquiring or
possibly avoiding illness, yet little is known about
lifestyle and risk of disease development in this group.
Aim: Investigate whether health anxiety is
prospectively associated with IHD, and whether a
potential association can be explained by the presence
or absence of established risk factors for
cardiovascular diseases.
Methods: Incident IHD was studied among 7052
participants in the community-based Hordaland Health
Study (HUSK) during 12 years follow-up by linkage to
the Cardiovascular Diseases in Norway (CVDNOR)
project. Scores above 90th centile of the Whiteley
Index defined health anxiety cases. Associations were
examined with the Cox proportional regression models.
Results: During follow-up, 6.1% of health anxiety
cases developed IHD compared with 3.0% of non-
cases, yielding a gender-adjusted HR of 2.12 (95% CI
1.52 to 2.95). After adjustments for established
cardiovascular risk factors, about 70% increased risk
of IHD was found among cases with health anxiety
(HR: 1.73 (95% CI 1.21 to 2.48)). The association
followed a dose–response pattern.
Conclusions: This finding corroborates and extends
the understanding of anxiety in various forms as a risk
factor for IHD. New evidence of negative consequences
over time underlines the importance of proper
diagnosis and treatment for health anxiety.
Health anxiety is characterised by persistent
preoccupation of having or acquiring a
serious illness, misattribution of bodily symp-
toms and urge to seek medical advice in the
absence of physical pathology.1 2 As a result,
persons with health anxiety stay activated and
alert to bodily symptoms in order to detect,
or even avoid, illness. Symptoms of health
anxiety may range from trivial to severe, and
in the most intense form including disease
conviction, the diagnostic criteria for hypo-
chondriasis might be met.3 As the leading
cause of premature death in Norway,4 as well
as in many other middle to high-income
countries, ischaemic heart disease (IHD) is
reasonably a frequent subject of concern
among persons with health anxiety.5 The risk
of IHD is largely influenced by health beha-
viours, and it has been estimated that close
to 90% of the burden of cardiovascular dis-
eases worldwide could be avoided with
healthier lifestyle in terms of diet, reduction
in tobacco consumption and increased level
of physical activity.6
Strengths and limitations of this study
▪ This prospective cohort study ensured complete
follow-up of participants in a community-based
health survey due to linkage with a nationwide
cardiovascular research project.
▪ The exposure health anxiety was assessed by
self-report with the Whiteley Index (WI), while
the outcome ischaemic heart disease (IHD) was
reported by physicians via patient administrative
systems in hospitals or at death certificates.
▪ WI do not discern between ‘imagined’ illness or
more legitimate reasons for concern. To reduce
the impact of high levels of health anxiety due to
actual illness, participants with prevalent or
12 months incident IHD were excluded.
▪ Low participation rate at the community-based
health survey of 63%, representing a greater
threat to the validity of studies estimating preva-
lence rather than risks.
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Anxiety disorders and IHD have several symptoms in
common, such as chest discomfort, palpitations, nausea,
sweating and tachypnoea. Additionally, anxiety disorders
in general are associated with increased risk of IHD.7 8
Following almost 250 000 persons for an average of
11 years, a meta-analysis from 2010 estimated 26%
increased risk of coronary heart disease among persons
with anxiety, independent of demographics, biological
factors and health behaviours.8 This analysis relied on
an overall heterogeneous measure of anxiety, counting
single studies using instruments assessing generalised
anxiety disorders, worry, panic attacks and phobic disor-
ders. The authors concluded that anxiety should be
regarded as an independent risk factor for coronary
heart disease, and that future research ought to confirm
the association using other valid and reliable measures
of anxiety. Certainly, the issue of causality between
anxiety and IHD has been of great interest, and a recent
meta-analysis provided evidence supporting a causal
association between anxiety and cardiovascular diseases
in general, suggesting anxiety to be targeted in prevent-
ive cardiology.9
Whether an increased risk of IHD also applies to
persons suffering from health anxiety has, to the best of
our knowledge, not been examined. Safety-seeking
behaviour such as monitoring and frequent check-ups of
symptoms associated with heart disease may contribute
to a reduced risk of IHD in health anxiety compared
with anxiety in general. Further, one could hypothesise
that individuals with health anxiety, due to their health
concerns, endorse a lifestyle that reduces the risk of
IHD. Yet, little is known about health-related behaviours
such as smoking, physical activity and alcohol consump-
tion in this group.
By linking a community-based health study with infor-
mation on hospitalisations and death due to IHD, the
aims of the present study were to examine (1) whether
health anxiety is prospectively associated with incident
IHD and (2) whether a potential association can be
explained by the presence or absence of established risk
factors for cardiovascular diseases.
METHODS
Study population: the Hordaland Health Study
The Hordaland Health Study (HUSK) is a community-
based health survey with baseline examinations con-
ducted during 1997–1999 as a collaboration between the
National Health Screening Service, the University of
Bergen and local health services.10 All persons born
1953–1957 who resided in Hordaland County on 31
December 1997 (n=29 400) received a personal invita-
tion to participate in the study. Data collection encom-
passed two sets of questionnaires and one brief physical
examination at which weight, height and blood pressure
were measured and a blood sample was drawn.
Questionnaire 1 was included with the mailed invitation
to participate in the study and was collected at the
health examination, during which participants randomly
were given one of two versions of questionnaire 2 to be
filled in at home and returned by mail. Participation
rate at the health examination was 63%. Of these, about
85% returned the second questionnaire. Persons who
did not meet at the examination or did not return the
second questionnaire received one reminder by mail.
Exposure: health anxiety measured by Whiteley Index
The presence of health anxiety was assessed by the
Whiteley Index (WI). Developed by Pilowsky11 in the
1960s, this widely used self-report instrument is consid-
ered a classic screening tool for health anxiety and hypo-
chondriasis.12 The index consists of 14 items, each
scored from 1 to 5, aiming to assess the disease dimen-
sions phobia, somatic preoccupation and disease convic-
tion. However, the three-dimensional factor structure
has been questioned in later studies,13 and the use of a
one-factor solution summarising the scores on all items
is recommended and widely used.13 The internal consist-
ency, stability and concurrent validity of WI is considered
to be good, both in samples from medical outpatient
clinics, general practice and the general population.13 In
the present study, scores for each of the 14 items were
summarised and the 90th centile was used as a cut-off
for cases of health anxiety, corresponding to the highest
prevalence estimate of illness anxiety disorder in the
general population reported in the DSM-V.1 In add-
itional analyses, scores on WI were operationalised in
quintiles and as a continuous variable.
Outcome: IHD
The research project ‘Cardiovascular diseases in Norway
1994–2009’ (CVDNOR) is a collaboration between the
University of Bergen and the Norwegian Knowledge
Center for the Health Services, and has retrospectively
collected data on hospitalisations and deaths due to
CVD during 1994–2009.14 15 In brief, data on hospital
stays coded with a CVD diagnosis as main or secondary
diagnoses were retrieved from the electronic Patient
Administrative System (PAS) in all Norwegian somatic
hospitals, while information on persons with a CVD
diagnosis on the death certificate, regardless of whether
they had been hospitalised for a CVD-related diagnosis,
was obtained from the Norwegian Cause of Death
Registry. Data quality is considered good.16 The main
outcome in the present study was incident IHD diag-
nosed at least 1 year after participation in HUSK and
until 31 December 2009, defined as a primary or sec-
ondary diagnosis or underlying cause of death with
ICD-10 code I20–I25.17 Participants in HUSK were
linked with CVDNOR through their personal identifica-
tion number, unique to each Norwegian resident.
Covariates
Based on knowledge of established risk factors for
IHD,18 we adjusted the analyses for several covariates
assessed at baseline in HUSK. Information on gender and
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age was obtained from the Norwegian Population
Registry. Based on self-reported information, we defined
persons as cohabiting if they had reported marital status
as ‘married’ or ‘partner’, highest achieved education was
categorised as ‘college or university’, ‘high school’ or
‘less than high school’. The number of alcohol units per
14 days was categorised according to tertiles in 0, 1–5
and ≥6 units, whereas physical activity was categorised as
mean hours with hard physical activity per week ranging
from 0 to ≥3, defined as perspirating and being out of
breath. Self-reported information on smoking was cate-
gorised as never, former and current. Height and weight
were measured at the examination, body mass index (BMI)
was calculated as weight (kg)/height (m)2, and cate-
gorised as underweight (≤19.9), normal (20.0–24.9),
overweight (25.0–29.9) and obese (≥30). Systolic blood
pressure (mm Hg), total cholesterol (mg/dL) and HDL
(mg/dL) were measured at the examination, and cate-
gorised in quintiles. Additionally, we utilised self-
reported data on the presence of diabetes and first-degree
relative with acute myocardial infarction (AMI) before 60 years.
Study sample and statistical procedures
The population eligible for inclusion in this study was
participants answering the WI, included in V.1 of ques-
tionnaire 2 in HUSK (n=7113). A total of 794 (11.2%)
participants had missing information on ≥1 of the 14
items on the WI. In the main analyses, participants
responding on 9–13 items of the index were given
imputed values equal to the mean score of the items
with valid responses (n=773), while persons with <9 valid
responses were excluded from the sample (n=21). To
reduce the risk of reverse causality due to high levels of
health anxiety among persons with prevalent and
early-onset incident IHD, we excluded persons who had
been hospitalised due to IHD from 1994 until participa-
tion in HUSK (n=30), as well as participants who were
hospitalised or died due to IHD during the first
12 months after the HUSK baseline examination (n=10).
This yielded a final sample of 7052 participants who
were followed from baseline until hospitalisation or
death, or until 31 December 2009, with a maximum
follow-up of 12 years. In a sensitivity analysis of the effect
of non-response, only persons with complete responses
on all 14 items on the WI were included (n=6279). A
recent confirmatory factor analysis (CFA) and item
response theory analysis using baseline data from HUSK
argued against the use of the 14-item WI as it did not
yield a satisfactory CFA fit, and suggested the use of a
6-item one-factor solution.19 Accordingly, a sensitivity ana-
lysis summarising only the 6 recommended items with
cut-off at score equal to the 90th centile was conducted.
The distribution of covariates by cases of health
anxiety was examined using descriptive statistics.
Associations between health anxiety and incident IHD
were examined using the Cox proportional regression
analyses in four models adjusted for (1) gender, (2)
gender, cohabiting and education (sociodemographic
factors), (3) gender, alcohol consumption, physical activ-
ity, diabetes, BMI, first-degree relative with AMI before
60 years, smoking, total cholesterol, HDL cholesterol
and systolic blood pressure (CVD risk factors) and (4)
all factors combined. The analyses were repeated strati-
fied by gender. Effect estimates are presented as HRs
with 95% CIs. To visually explore the association
between health anxiety and risk of IHD, we used the
Cox proportional hazards regression model fitting WI
scores using restricted cubic splines with three knots.20
Listwise deletion was employed for cases with missing
information on the covariates in the multivariate ana-
lyses (between 0% and 20%). All analyses were con-
ducted in SPSS (IBM Corp. Released 2013. IBM SPSS
Statistics for Windows VA, New York: IBM Corp), and
figures were constructed in Stata (StataCorp. 2013. Stata
Statistical Software: Release V.13. College Station TSL).
Ethics
The study protocol was approved by the Regional Ethics
Committee of Western Norway (REK) (ref 2013/1764)
and the Norwegian Data Inspectorate. The linkage
between HUSK and CVDNOR was approved by REK.
Written informed consent was obtained from all partici-
pants at the time of the baseline health examination.
RESULTS
Participants who scored ≥31 on WI constituted the
90th centile and were defined as cases with health
anxiety. Among these, the mean WI score was 36.8 (SE
0.22), while the mean score among non-cases was 20.9
(SE 0.05). Health anxiety was positively associated with
disadvantageous responses on most of the a priori
selected risk factors for IHD, except for lower than
usual alcohol consumption. No differences in the
distribution of systolic blood pressure were found
(table 1).
After excluding persons with an ischaemic heart event
(hospitalisation or death) occurring the first year after
baseline, 234 (3.3%) participants had an ischaemic
heart event during follow-up, 6.1% of cases compared
with 3.0% of non-cases. The mean time to event was
7.3 years (SE 2.91). Gender-adjusted HR for the associ-
ation between cases of health anxiety and an incident
IHD event was 2.12 (95% CI 1.52 to 2.95) (table 2).
Established CVD risk factors explained part of the associ-
ation; however, the fully adjusted model showed 73%
increased risk of incident IHD among cases with health
anxiety (table 2). Among the included single risk
factors, separate adjustments for smoking, HDL choles-
terol and education attenuated the association most
(data not shown). Gender-stratified analyses gave slightly
higher effect estimates for women than men (table 2),
but no significant gender interaction was found.
Further, the association between health anxiety and IHD
was no longer significant for women after adjustments
for CVD risk factors and all covariates combined.
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Table 1 Characteristics of 7052 participants in the Hordaland Health Study (HUSK) without prevalent or 12-month incident









Age‡ 43.1 (1.55) 43.2 (1.61) 0.005§
Missing 0 (0) 0 (0)
Gender (male) 3305 (52.1) 361 (50.8) 0.521¶
Missing 0 (0) 0 (0)
Cohabiting 4754 (75.0) 470 (66.2) <0.001¶
Missing 0 (0) 0 (0)
Education
Less than high school 1035 (16.3) 168 (23.7) <0.001¶
High school 2939 (46.3) 323 (45.5)
College or university 2318 (36.5) 213 (30.0)
Missing 50 (0.8) 6 (0.8)
Usual alcohol consumption per 14 days (units)
0 1587 (25.0) 197 (27.7) 0.008¶
1–5 1744 (27.5) 159 (22.4)
≥6 1765 (27.8) 191 (26.9)
Missing 1246 (19.6) 163 (23.9)
Activity (hours per week)
0 1704 (26.9) 231 (32.5) 0.002¶
<1 1704 (26.9) 204 (28.7)
1–2 1789 (28.2) 174 (24.5)
≥3 919 (14.5) 77 (10.8)
Missing 226 (3.6) 24 (3.4)
Diabetes (yes) 61 (1.0) 15 (2.1) 0.006¶
Missing 34 (0.5) 7 (1.0)
First-degree relative with AMI before 60 years of
age (yes)
957 (15.1) 128 (18.0) 0.004¶
Missing or unknown 196 (3.1) 34 (4.8)
BMI
≤19.9 254 (4.0) 32 (4.5) 0.011¶
20.0–24.9 2909 (45.7) 285 (40.1)
25.0–29.9 2476 (39.0) 288 (40.6)
≥30.0 704 (11.1) 103 (14.5)
Missing 7 (0.1) 2 (0.3)
Total cholesterol quintiles (mg/dL)
1st (<183.7) 1265 (20.0) 133 (18.8) 0.552¶
2nd (≥183.7, <202.3) 1262 (19.9) 141 (19.9)
3rd (≥202.3, <221.2) 1262 (19.9) 141 (19.9)
4th (≥221.2, <244.8) 1282 (20.2) 134 (18.9)
5th (≥244.8) 1261 (19.9) 159 (22.5)
Missing 11 (0.2) 2 (0.3)
HDL quintiles (mg/dL)
1st (<37.0) 1173 (18.5) 172 (24.3) <0.001¶
2nd (≥37.0, <43.0) 1235 (19.5) 153 (21.6)
3rd (≥43.0, <49.5) 1302 (20.6) 136 (19.2)
4th (≥49.5, <58.1) 1279 (20.2) 126 (17.8)
5th (≥58.1) 1342 (21.2) 121 (17.1)
Missing 11 (0.2) 2 (0.3)
Systolic BP quintiles (mm Hg) 128.5 (0.17) 128.3 (0.53
1st (<116.7) 1247 (19.9) 155 (22.2) 0.536¶
2nd (≥116.7, <123.7) 1247 (19.9) 134 (19.2)
3rd (≥123.7, <130.3) 1189 (19.0) 119 (17.0)
4th (≥130.3, <139.0) 1129 (20.6) 143 (20.5)
5th (≥139.0) 1288 (20.6) 147 (21.1)
Missing 16 (0.3) 2 (0.3)
Continued
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Restricting these analyses to participants with com-
plete responses on all the WI items yielded similar
results for the association between health anxiety and
incident IHD (gender-adjusted HR: 2.19 (95% CI 1.57
to 3.07), fully adjusted HR: 1.80 (95% CI 1.25 to 2.59)).
Although sensitivity analysis including only the 6 items
on the WI previously shown to yield the best factor struc-
ture19 slightly attenuated the strength of the association,
this analysis also confirmed that high levels of health
anxiety was significantly associated with incident IHD
(gender-adjusted HR: 1.83 (95% CI 1.29 to 2.59), fully
adjusted HR: 1.50 (95% CI 1.03 to 2.18)).
Operationalising scores on the WI in quintiles and as
a continuous variable revealed a dose–response pattern of
the association (table 3 and figure 1). A significant trend
with increased strength of the association by increasing
scores on WI was found in all four models (table 3),
while figure 1 revealed a linear association between scores
on WI and subsequent risk of IHD, in the gender
adjusted (part A) and fully adjusted models (part B).
Health anxiety often exist comorbid to other psychi-
atric disorders, such as general anxiety and depression.21
Additionally, regarded as an anxiety disorder, health
anxiety obviously shares many features with anxiety in
general, and a sharp distinction between the conditions
is difficult to draw. Nevertheless, in an attempt to
investigate a possible more specific effect of health
anxiety on risk of IHD, we conducted post hoc analyses
adjusting for the presence of anxiety and depression at
baseline in HUSK measured by the Hospital Anxiety and
Depression Scale, subscale for anxiety (HADS-a) and
depression (HADS-d).22 Cases with health anxiety had
the mean HADS-a and HADS-d of 8.01 (SE: 0.15) and
5.54 (SE: 0.16), while non-cases scored 4.27 (SE 0.04)
and 2.89 (SE 0.36), respectively. The Pearson’s correl-
ation coefficient between WI and HADS-a and Hads-d
were 0.48 (p=0.00) and 0.37 (p=0.00), respectively. HR
for the association between health anxiety and IHD
adjusted for gender and HADS-a was 1.65 (95% CI 1.14
to 2.38), corresponding HR adjusted for gender and
HADS-d was 1.89 (95% CI 1.33 to 2.59), while the HR
adjusted for gender and HADS-a and HADS-d was 1.64
(95% CI 1.14 to 2.37). However, adding measures of
anxiety to the fully adjusted model outlined in tables 2
and 3 resulted in a no longer significant association
between health anxiety and IHD, evident from an HR of
1.33 (95% CI 0.90 to 1.98) for the fully adjusted model in
addition to adjustments for HADS-a and HR of 1.31 (95%
CI 0.88 to 1.97) for the fully adjusted model in addition
to adjustments for HADS-a and HADS-d. Including adjust-
ments of HADS-d only to the previously fully adjusted
model yielded an HR of 1.56 (95% CI 1.06 to 2.28).
Table 2 HRs for incident ischemic heart disease (IHD) comparing cases with and without health anxiety*
Total sample (n=7052) Men (n=3666) Women (n=3386)
234 (3.3) 173 (4.7) 61 (1.8)
N events (%) HR (95% CI) HR (95% CI) HR (95% CI)
Adjusted for gender 2.12 (1.52 to 2.95) 2.09 (1.42 to 3.09) 2.19 (1.16 to 4.11)
Adjusted for sociodemographic factors† 2.00 (1.43 to 2.79) 1.93 (1.30 to 2.86) 2.14 (1.14 to 4.04)
Adjusted for CVD risk factors‡ 1.73 (1.22 to 2.47) 1.79 (1.18 to 2.71) 1.61 (0.80 to 3.25)
Adjusted for all covariates§ 1.73 (1.21 to 2.48) 1.78 (1.17 to 2.71) 1.58 (0.78 to 3.20)
IHD were events occurring 1–12 years after baseline participation in the Hordaland Health Study (HUSK). Estimates are adjusted separately
for blocks of covariates and all covariates combined.
*Score equal to or above 90th centile of Whiteley Index (≥31 points).
†Gender, cohabiting and education.
‡Gender, alcohol consumption, physical activity, diabetes, BMI, first-degree relative with AMI before 60 years, smoking, total cholesterol, HDL
cholesterol, systolic blood pressure.
§Gender, cohabiting, education, alcohol consumption, physical activity, diabetes, BMI, first-degree relative with AMI before 60 years, smoking,











Current 2488 (39.2) 341 (48.0) <0.001¶
Former 1783 (28.1) 187 (26.3)
Never 2064 (32.5) 181 (25.5)
Missing 7 (0.1) 1 (0.1)
*Score under 90th centile (<31 points) of Whiteley Index.
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DISCUSSION
Using self-reported information on health anxiety from
a community-based study linked with data on hospitalisa-
tions and death, we found a dose–response association
between increasing levels of health anxiety and risk of
incident IHD. Relative to persons with lower levels of
health anxiety, persons with health anxiety defined as
scores on the WI equal to or above the 90th centile had
∼70% increased risk of incident IHD events after adjust-
ment for established CVD risk factors. The finding was
confirmed in sensitivity analyses according to a recent
CFA and when solely including persons with complete
responses on the exposure variable.
Health anxiety and risk factors for IHD
Relative to persons with low levels of health anxiety,
persons with high levels reported less hours of hard
physical activity per week, higher prevalence of smoking,
yet fewer units of alcohol consumed on average per week.
With the exception of an Australian population-based
study showing approximately twofold odds of current
smoking among participants with health anxiety,21 health
behaviours in health anxiety are sparsely examined.
Lower levels of hard physical activity could possibly be
explained by fear of forcing or putting strain on the body,
while the divergent results on substance use in terms of
higher levels of smoking yet lower levels of alcohol use
are more difficult to explain. One may speculate that
smoking can be used as a tranquillizer in an attempt to
relieve tension, while the use of alcohol reduces bodily
control, and is therefore perhaps more often avoided
among persons with health anxiety.
Health anxiety and incident IHD
Several studies have established a prospective association
between anxiety disorders and IHD,7 8 and there is
evidence of a causal association between anxiety and car-
diovascular diseases.9 Findings from the Norwegian lon-
gitudinal Nord-Trøndelag Health Study (HUNT) suggest
a possible dose–response pattern between anxiety, mea-
sured by the anxiety subscale of the Hospital Anxiety
and Depression Scale, and incident myocardial infarc-
tion.23 However, in that study, the association was fully
explained by adjusting for gender, age, cohabiting, edu-
cation, smoking, physical activity, BMI, total cholesterol,
diabetes and systolic blood pressure.23 This contrasts our
finding of a dose–response association between increas-
ing levels of health anxiety and IHD persisting after
adjustments for a range of established CVD risk factors.
The novel finding of an association between health
anxiety and incident IHD is in line with, but additionally
extends, the current understanding of anxiety as an
independent risk factor for incident IHD and cardiac
mortality.8 It further indicates that characteristic behav-
iour among persons with health anxiety, such as moni-
toring and frequent check-ups of symptoms, does not
reduce the risk of IHD events. The persistent and exag-
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continuous and high activation of the hypothalamic–pitu-
itary–adrenal axis, placing strain on bodily systems and, in
turn, increasing the risk of cardiovascular diseases.
Reduced heart rate variability and acceleration of the ath-
erosclerotic process has been suggested as mechanisms
possibly explaining the increased risk of IHD among
persons with anxiety.24 25 In a French study investigating
over 700 persons free of coronary artery disease at base-
line, high levels of anxiety was associated with an almost
twofold increase in thickness of the intima media of the
carotid arteries, as well as more than threefold increased
risk of plaque occurrence during 4 years of follow-up.24
In the gender-stratified analyses in table 2, the associ-
ation between health anxiety and IHD was no longer sig-
nificant for women after adjustments for established
CVD risk factors. This finding must be interpreted with
caution, as no significant gender interaction was found.
Further, no previous studies on the prospective associ-
ation between anxiety and risk of IHD or cardiovascular
diseases have, to the best of our knowledge, found evi-
dence of effect modification by gender.8 9 23 In the
general population, women develop IHD one decade
later in life compared with men.26 Thus, our findings
are likely explained by the expected low event rate of
IHD for women in this relatively young cohort of partici-
pants followed from their 40s into early 60s, resulting in
wider CIs and non-significant associations when includ-
ing numerous covariates in the more adjusted models.
Limitations
Despite a prospective design linking a community-based
health survey with comprehensive information on subse-
quent hospitalisations and death ensuring complete
follow-up of participants, this study is also affected by
limitations. First, even though the WI is a validated and
frequently used instrument to assess health anxiety, it
relies on self-reported symptoms and does not discern
between health anxiety due to ‘imagined’ illness or
more legitimate reasons for concern, such as known risk
for IHD. We tried to reduce the impact of high levels of
health anxiety due to actual illness by excluding partici-
pants with prevalent and 12 months incident IHD. As
the CVDNOR project spans the years 1994–2009, we
could not exclude participants in HUSK diagnosed with
IHD earlier than 1994; however, we argue that this
represents a minor bias as the prevalence of IHD among
persons younger than 40 years of age is very low.26
Further, if the atherosclerotic process precedes health
anxiety, our results might be affected by residual con-
founding as we lack data in HUSK on subclinical IHD
and atherosclerosis. Arguing against this, a Swedish
cohort of close to 50 000 men aged 18–20 years exam-
ined for military service, presumably before start of the
atherosclerotic process, confirmed that anxiety present
in early adulthood independently predicted subsequent
coronary heart disease.7 Second, low participation rate
and non-participation always challenges the generalis-
ability of results from population-based studies. A previ-
ous study of the HUSK population showed higher risk of
being awarded disability pension for neurotic, stress-
related or somatoform disorders as well as for diseases in
the circulatory system among nonparticipants.27 In
general, non-participation represents a greater threat to
the validity of results from studies estimating prevalence
rather than risks, and we argue that this is a minor
threat to the internal validity of our results; nevertheless,
an underestimation of the true association cannot be
excluded. Third, health anxiety was associated with
established risk factors for IHD such as diabetes, lower
levels of education and living alone. These covariates
may be confounders for the association between health
anxiety and IHD, and were therefore adjusted for in the
Figure 1 Associations (HRs) between score on Whiteley Index and risk of incident ischaemic heart disease events 1–12 years
after participation in the Hordaland Health Study (HUSK). Score on Whiteley. Index is fitted using restricted cubic splines with
three knots in the Cox proportional hazard regression models. Solid line represents HR and shaded area 95% CI. (A) Model
adjusted for gender only. (B) Fully adjusted model, including gender, cohabiting, education, alcohol consumption, physical
activity, diabetes, BMI, first-degree relative with AMI before 60 years, smoking, total cholesterol, HDL cholesterol, systolic blood
pressure.
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analyses. However, some of them may also be regarded
as mediators in the association, as disadvantageous life-
style, living without a partner and low educational level
could be the result of anxiety earlier in life. By adjusting
for such possible mediators, our estimates of the associ-
ation between health anxiety and IHD will represent an
underestimation of the true association. Fourth, we did
not have information on a range of additional condi-
tions that are likely to be associated with both health
anxiety and increased risk of IHD, such as, for example,
pulmonary diseases and malignancies. As a result,
residual confounding cannot be ruled out. Finally, a
sharp distinction between health anxiety and other psy-
chiatric conditions is challenging to draw, as health
anxiety often exists comorbid to other psychiatric disor-
ders,21 and, regarded an anxiety disorder, obviously
shares many features of anxiety in general. To reduce
the risk of overadjustments, we decided against includ-
ing measures of anxiety and depression in the main
model of this study as symptoms of health anxiety correl-
ate to a large extent with symptoms of these conditions.
This is particularly evident for anxiety in general,
reflected in the relatively strong correlation between WI
and HADS-a likely explaining the no longer significant
finding between health anxiety and IHD when including
measures of anxiety in the fully adjusted model.
Implications
Persons with high levels of health anxiety have about
70% increased risk of IHD relative to persons with lower
levels after adjustments for established CVD risk factors,
including lifestyle factors. This finding is of public
health significance as IHD is one of the main causes of
morbidity and mortality worldwide.4 If persons with high
levels of health anxiety stay alert with the intention to
better ‘control’ and ‘detect’ early signs of severe somatic
diseases, it might contribute to unintentional harmful
effects as the autonomous activation associated with
anxiety in general likely is associated with increased risk
of IHD. These findings illustrate the dilemma for clini-
cians between reassuring the patient that current phys-
ical symptoms of anxiety do not represent heart disease,
contrasted against the emerging knowledge on how
anxiety, over time, may be causally associated with
increased risk of IHD.9 At best, this finding might
encourage patients to seek treatment for health anxiety
and to trust their heart.
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